COVID-19-related delays of botulinum toxin injections have a negative impact on the quality of life of patients with dystonia and spasticity: a single-center ambulatory care study

Consensus guidelines for botulinum toxin therapy: general algorithms and dosing tables for dystonia and spasticity

(2021) Dirk Dressler et al.   JOURNAL OF NEURAL TRANSMISSION

The Impact of SARS-CoV-2 Pandemic Lockdown on a Botulinum Toxin Outpatient Clinic in Germany

(2021) Sara Samadzadeh et al.   Toxins

The effects of COVID-19 pandemic countermeasures on patients receiving botulinum toxin therapy and on their caregivers: a study from an Italian cohort

(2021) Domiziano Tarantino et al.   NEUROLOGICAL SCIENCES

Discontinuation of botulinum neurotoxin type-A treatment during COVID-19 pandemic: an Italian survey in post stroke and traumatic brain injury patients living with spasticity

(2021) Andrea SANTAMATO et al.   European Journal of Physical and Rehabilitation Medicine

Delay in OnabotulinumtoxinA Treatment During the COVID‐19 Pandemic‐Perspectives from a Virus Hotspot

(2020) Ashhar Ali   HEADACHE

Patient Perspectives on the Therapeutic Profile of Botulinum Neurotoxin Type A in Spasticity

(2020) Jorge Jacinto et al.   Frontiers in Neurology

Botulinum toxin therapy in the SARS-CoV-2 pandemic: patient perceptions from a German cohort

(2020) Dirk Dressler et al.   JOURNAL OF NEURAL TRANSMISSION

Spasticity Treatment During COVID-19 Pandemic: Clinical Recommendations

(2020) Alessio Baricich et al.   Frontiers in Neurology

Botulinum toxin therapy during the Covid 19 outbreak: Experience of an Italian multidisciplinary team

(2020) Elena Ranza et al.   EUROPEAN JOURNAL OF NEUROLOGY

Duration of Symptom Relief Between Injections for AbobotulinumtoxinA (Dysport®) in Spastic Paresis and Cervical Dystonia: Comparison of Evidence From Clinical Studies

(2020) Alberto Esquenazi et al.   Frontiers in Neurology

Impact of COVID-19 on neurological patients attending a botulinum toxin service

(2020) Roberto Erro et al.   NEUROLOGICAL SCIENCES

Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache

(2016) David M. Simpson et al.   NEUROLOGY